Advertisement

Topics

Steve Luckenbach Company Profile

10:40 EST 17th December 2018 | BioPortfolio


News Articles [148 Associated News Articles listed on BioPortfolio]

Apples Steve Wozniak gründet Risiko-Fonds für Blockchain

Der Risikokapitalfonds von Apple-Mitgründer Steve Wozniak wird in Blockchain-Startups investieren und nutzt einen eigenen Token. TOP-Meldung Apples Steve Wozniak gründet Blockchain-fokussierten Ris....

Steve Yemm appointed CEO of BioData

BioData has announced the appointment of Steve Yemm as CEO, following a decade of growth in the adoption of its flagship product Labguru

MTC-ABAG Executive Director Steve Heminger Announces Retirement

SAN FRANCISCO, July 25, 2018 /PRNewswire/ -- Steve Heminger, executive director of the Metropolitan Transportation Commission (MTC) since 2001 and of the Association of Bay Read more...

Changing the rules of the game. Steve Bates, CEO, BIA

Steve Bates, CEO, BIA talks to Nigel Borshell about their involvement in the European Adaptive Licensing scheme and the UK's Early Access scheme and how these initiatives can help companies find a new...

Steve Ferrara loses race to become first radiologist elected to Congress

The interventional radiologist, and former chief medical officer for the U.S. Navy, Steve Ferrara, MD, lost to his Democratic challenger and former Phoenix Mayor, Greg Stanton in the race to repres...

Experienced Marketeer Joins the Team

Steve Abbott, a CIM qualified marketing professional, brings to his role more than ten years of experience in business to business marketing communications in the science, engineering and renewable se...

Stephen William Valentine Coppinger

Stephen William Valentine Coppinger (“Steve”) was born in Vancouver, Canada. His father served in the Canadian Army as a gynaecologist and obstetrician, and Steve spent part of his childhood at Fo...

An Interventional Approach to Pancreatic Cancer | Steve's Story

Being diagnosed with advanced metastatic pancreatic cancer was a grim experience for Steve Price. But thanks to his doctors at Weill Cornell Medicine and NewYork-Presbyterian, state-of-the-art interve...

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

A Multicenter Study of NAP (AL-108) in Schizophrenia

The TURNS is a NIMH-funded contract for the evaluation of new compounds for the treatment of cognitive impairments in schizophrenia (HHSN 27820044 1003C; P.I.: Steve Marder, M.D.). Despite...

Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia

The TURNS is a NIMH-funded contract for the evaluation of new compounds for the treatment of cognitive impairments in schizophrenia (HHSN 27820044 1003C; P.I.: Steve Marder, M.D.). Despite...

Companies [40 Associated Companies listed on BioPortfolio]

Steve Luckenbach

Mölnlycke Health Care AB

“On behalf of the Board, I thank Steve for his many years of service and commitment.  Steve’s leadership has been a key contributor to the Company’s success to d...

QDI Strategies, Inc.

QDI StrategiesDuring the late 1970's and the 1980's, several of the principals of QDI Strategies were at a midsize consulting firm helping clients develop various types of business and marketing strat...

Steve Harden

Steve Harden has written numerous articles on patient safety appearing in Patient Safety and Quality Health Care and other publications. He is also the co-author of the book CRM: The Flight Plan for L...

Steve M. Parker, Jr.

More Information about "Steve Luckenbach" on BioPortfolio

We have published hundreds of Steve Luckenbach news stories on BioPortfolio along with dozens of Steve Luckenbach Clinical Trials and PubMed Articles about Steve Luckenbach for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Steve Luckenbach Companies in our database. You can also find out about relevant Steve Luckenbach Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record